Bullfrog ai announces licensing agreement with johns hopkins university for oncology asset

Mebendazole prodrug license further expands the company's development pipeline, which includes a phase 2 ready novel formulation of mebendazole for cancer treatment mebendazole prodrug license further expands the company's development pipeline, which includes a phase 2 ready novel formulation of mebendazole for cancer treatment
BFRG Ratings Summary
BFRG Quant Ranking